Seth Harmon - Sep 12, 2023 Form 3 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role
Exhibit 24 - Power of Attorney Senior Vice President of Finance
Signature
/s/ Lara Meisner, Attorney-in-Fact for Seth Harmon
Stock symbol
VRDN
Transactions as of
Sep 12, 2023
Transactions value $
$0
Form type
3
Date filed
9/19/2023, 04:30 PM
Next filing
Nov 13, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VRDN Stock Option (Right to Buy) Sep 12, 2023 Common Stock 175K $24.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on June 1, 2024 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date.

Remarks:

Exhibit 24 - Power of Attorney Senior Vice President of Finance